Cargando…
On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
The marketing and sale of oxycodone (OxyContin) by Purdue Pharma has commanded a great deal of legal and policy attention due to the drug’s central role in the ongoing overdose crisis. However, little is known about the basis for OxyContin’s approval by regulators, such as Health Canada in 1996. Tak...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523806/ https://www.ncbi.nlm.nih.gov/pubmed/35924783 http://dx.doi.org/10.1177/17407745221108436 |